Clinical evidence has also indicated a correlation between S100A4 overexpression and prognosis in several cancer types, such as bladder cancer [11], breast cancer [12], esophageal-squamous cancer [13], gastric cancer [14], lung cancer [15], and pancreatic cancer [16]. Here, S100A4 is linked to cancer.